Who is sponsoring NCT06172062?

NCT06172062 is sponsored by Xinrui Zhu，MD.

What drugs are being tested in NCT06172062?

Interventions in NCT06172062: laparoscopic pancreaticoduodenectomy.

What condition does NCT06172062 study?

NCT06172062 studies Laparoscopic Pancreaticoduodenectomy.

Is NCT06172062 still recruiting?

NCT06172062 is currently status unknown. Last updated 15 December 2023.

Last reviewed 2023-12-15 · How we verify

NCT06172062

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Establishment and Application of an Artificial Intelligence Algorithm for Automatic Identification of Intraoperative Bleeding During Laparoscopic Pancreaticoduodenectomy

Status unknown Last updated 15 December 2023

What this trial tests

trial testing laparoscopic pancreaticoduodenectomy in Laparoscopic Pancreaticoduodenectomy in 400 participants. Status unknown.

Timeline

20 July 2023

Primary endpoint
30 December 2023

30 March 2024

Quick facts

Lead sponsor	Xinrui Zhu，MD
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	400
Start date	20 July 2023
Primary completion	30 December 2023
Estimated completion	30 March 2024
Sites	1 location across China

Drugs / interventions tested

laparoscopic pancreaticoduodenectomy

Conditions studied

Laparoscopic Pancreaticoduodenectomy — all drugs for Laparoscopic Pancreaticoduodenectomy →

Sponsor

Xinrui Zhu，MD — full company profile →

Who can join

Eligibility, any sex, with Laparoscopic Pancreaticoduodenectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgeons will label surgical videos of laparoscopic pancreaticoduodenectomy with bleeding information from multicenter. The labeled surgical video will be used as training material to train the algorithmic model so as to build an artificial intelligence algorithm that can automatically identify intraoperative bleeding in this surgery. Then, we will test the performance capability of the algorithm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of laparoscopic pancreaticoduodenectomy

Trials testing the same drug.

NCT06128603 — Analysis of Intraoperative Bleeding Characteristics in Laparoscopic Pancreaticoduodenectomy · unknown
NCT05755607 — A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD · NA · not yet recruiting

Other Xinrui Zhu，MD trials

Trials by the same sponsor.

NCT06128603 — Analysis of Intraoperative Bleeding Characteristics in Laparoscopic Pancreaticoduodenectomy · unknown
NCT05905549 — Extended Pancreatic Transection Versus Conventional Pancreatic Transection During Laparoscopic Pancreaticoduodenectomy · unknown
NCT04997850 — The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) · Phase 1, PHASE2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06172062 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xinrui Zhu，MD
Last refreshed: 15 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06172062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing